Available PET Radiopharmaceuticals for Human Use at MGH PET Core
Revision: January 2016
F-18
FDG*
FES (estrogen receptor)†
T807 (tau protein)‡
FPEB (mGlur5)
BFPET (myocardial perfusion)
GE180 (TSPO/PBR)†
FLT (cellular proliferation)†
C-11
PiB (amlyoid)‡
Altropane (Dopamine transport)
Raclopride (D2/D3 receptor imaging)
Methionine (amino acid uptake)†
Acetate (fatty acid synthase)
CO (gas)
Rolipram (PDE-4 receptor imaging)
P943 (5-HT1B)
N-13
Ammonia*
N2 in Saline (lung perfusion imaging)
O-15
C15O2 (blood flow imaging)
Currently in Development/Validation for Human Use at the MGH PET Core
F-18
THK 5351/GE-216 (tau protein)‡
FMISO (hypoxia)‡
MK-6240 (tau protein)‡
GE179 (NMDA) ‡
C-11
PBR-28 (TSPO/PBR)‡
(S,S)-[11C]Methylreboxetine (MeNR/MRB) – targets NET
*FDA approved
†Active IND
‡Pending/Planned IND